Sudden cardiac death screening

Jump to navigation Jump to search

Sudden cardiac death Microchapters


Patient Information

Sudden Cardiac versus Non-Cardiac Death


Historical Perspective




Definitions and Diagnosis

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound

CT scan


Other Imaging Findings

Other Diagnostic Studies

Urgent Treatment

Post Arrest Care and Prevention

Ethical Issues

Sudden cardiac death screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Sudden cardiac death screening

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sudden cardiac death screening

CDC on Sudden cardiac death screening

Sudden cardiac death screening in the news

Blogs on Sudden cardiac death screening

Directions to Hospitals Treating Sudden cardiac death

Risk calculators and risk factors for Sudden cardiac death screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD[3]



2022 ESC Guidelines for the management of patients with ventricular arrythymias and the prevention of sudden cardiac death [6]

Recommendations for evaluation of relatives of sudden arrhythmic death syndrome decedents
Class I (Level of Evidence: B)


  1. 1.0 1.1 Wahbi K, Ben Yaou R, Gandjbakhch E, Anselme F, Gossios T, Lakdawala NK; et al. (2019). "Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies". Circulation. 140 (4): 293–302. doi:10.1161/CIRCULATIONAHA.118.039410. PMID 31155932.
  2. 2.0 2.1 Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A; et al. (2019). "A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy". Eur Heart J. 40 (23): 1850–1858. doi:10.1093/eurheartj/ehz103. PMC 6568197 Check |pmc= value (help). PMID 30915475.
  3. 3.0 3.1 Miron A, Lafreniere-Roula M, Steve Fan CP, Armstrong KR, Dragulescu A, Papaz T; et al. (2020). "A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy". Circulation. 142 (3): 217–229. doi:10.1161/CIRCULATIONAHA.120.047235. PMC 7365676 Check |pmc= value (help). PMID 32418493 Check |pmid= value (help).
  4. 4.0 4.1 Norrish G, Ding T, Field E, Ziólkowska L, Olivotto I, Limongelli G; et al. (2019). "Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)". JAMA Cardiol. 4 (9): 918–927. doi:10.1001/jamacardio.2019.2861. PMC 6694401 Check |pmc= value (help). PMID 31411652.
  5. 5.0 5.1 O'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C; et al. (2014). "A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)". Eur Heart J. 35 (30): 2010–20. doi:10.1093/eurheartj/eht439. PMID 24126876.
  6. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA; et al. (2022). "2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". Eur Heart J. 43 (40): 3997–4126. doi:10.1093/eurheartj/ehac262. PMID 36017572 Check |pmid= value (help).

Template:WH Template:WS